Side-by-side financials for CLLS and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLLS | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | - | -$1.13B |
| SEC filings | 517 | 782 |
Full pages: Cellectis S.A. and Revolution Medicines, Inc., or browse the full rankings.